Diabetic nephropathy diagnostic kit and application thereof
A technology for diabetic nephropathy and diagnostic reagents, applied in the field of diagnostic kits for diabetic nephropathy, which can solve the problems of lack of effective markers for diabetic nephropathy and cumbersome diagnostic process of diabetic nephropathy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] In this verification study, a total of 182 subjects with known physical conditions were selected, including 50 healthy subjects, 33 diabetic patients, 33 diabetic nephropathy stage 3 patients, 27 diabetic nephropathy stage 4 subjects, and 39 diabetic nephropathy stage 5 subjects. Mongensen staging method, age 40-75 years.
[0021] 1. Inosine, adenosine combined with S-adenosyl homocysteine (SAH)
[0022] Refer to the table below for the indication range:
[0023] Table 2
[0024] course of disease Inosinemg / L Adenosinemg / L SAH μg / L Diabetic Kidney Disease Stage 4 0.288~0.350 0.509~0.571 16.83~24.28 Diabetic Kidney Disease Stage 5 0.855~1.034 1.712~2.028 108.7~124.8
[0025] Prepare gradient concentration solutions of inosine, adenosine and SAH standard substances respectively. 0.04μg / mL, 0.0625μg / mL, 0.125μg / mL, 0.2μg / mL, 0.4μg / mL; SAH concentration gradient: 2 ng / mL, 8 ng / mL, 40 ng / mL, 160 ng / mL mL, 320 ng / mL.
[0026] Use li...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com